FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk, expanding the product’s regulatory authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

SUPPL AP for NOVOLOG (INSULIN ASPART)